about
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinomaMetadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 inductionmicroRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function.Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesisIdentification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer.LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway.Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis.Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.MicroRNA Control of p53
P50
Q28239503-06F58B41-2041-4AC8-80DE-142773EECA24Q34110914-AC76C98D-CC9B-4BDA-9850-AB38CB875745Q34372540-C8781A8D-60D6-45F3-9AC8-33B8205000EBQ35552029-74BC6B4E-663D-4910-855F-BE93D933D4CCQ36032139-AA543D6B-8A88-4AAB-94AE-6865E94B96B2Q36568490-C542CA8E-17F1-4BC9-9273-C9A4C00981C6Q36782261-972CF3BB-900E-4A9C-8758-979DF60C6745Q36962411-7B5609E4-1D72-434C-A1A9-F4AD2AAD9C5EQ36997999-8B9617D7-10EE-4E8C-BFBF-DA800CB85376Q37650965-2D3D345B-C9E1-4534-8CC0-CF449893F713Q37656224-1DAEE535-3E2D-4FED-98D4-7CF9FFDF8039Q37718451-BFE4DB9B-3800-416B-8318-434F713A6B85Q38889305-62687D3B-C5B5-4036-B41B-90A03F43CD2BQ39229004-22683904-827B-453C-BED7-99462AEBAFFEQ41633301-3E9E8660-82E9-47F0-B8B5-7D7B08A10E32Q47132104-9EE3EF7C-865D-468D-8DE1-E910959D75E7Q51761333-5D87FEBE-454A-401B-826E-965A9D8C704DQ89268424-77604079-997C-4F13-B4CC-0A2F427D29E9
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-5529-1907
@en
name
Yuhan Zhao
@ast
Yuhan Zhao
@en
Yuhan Zhao
@es
Yuhan Zhao
@nl
type
label
Yuhan Zhao
@ast
Yuhan Zhao
@en
Yuhan Zhao
@es
Yuhan Zhao
@nl
prefLabel
Yuhan Zhao
@ast
Yuhan Zhao
@en
Yuhan Zhao
@es
Yuhan Zhao
@nl
P106
P31
P496
0000-0001-5529-1907